Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home Lifestyle Health and Longevity

Stone Ridge’s Predictable Cash Flows: Longevity Income ETFs

by Team Lumida
July 4, 2024
in Health and Longevity
Reading Time: 3 mins read
A A
0
Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

  1. Stone Ridge introduces 32 Longevity Income ETFs targeting predictable monthly cash flows for retirees.
  2. Funds invest in US Treasuries and government money markets, with options for inflation protection.
  3. Competitors like BlackRock and T Rowe Price also eye post-retirement income market.

What Happened?

Stone Ridge has filed to launch 32 Longevity Income ETFs, specifically designed to provide regular monthly income for elderly investors. These ETFs target investors who will turn 100 between 2048 and 2063, generating income starting 20 years before that. The funds invest initially in US Treasuries and government money market funds.

A companion suite, the Inflation-Protected Longevity Income ETFs, will invest in Treasury Inflation-Protected Securities. Each ETF aims to generate monthly distributions of $0.0833 per share, totaling $1 per share annually.

Why It Matters?

The introduction of these ETFs addresses a significant gap in the market. Many products focus on asset accumulation rather than converting those assets into predictable cash flows. Stone Ridge’s offering provides a solution for retirees seeking steady income, crucial for financial planning.

The funds’ design, with options for term-income distributions or converting shares into a closed-end fund, offers flexibility. Additionally, the involvement of a market leader in income annuities for actuarial services ensures robust financial planning.

What’s Next?

As competition intensifies among fund firms for post-retirement assets, Stone Ridge’s ETFs could set a new standard. With fees yet to be disclosed, investors should watch for cost details. The funds liquidate in December of the target year, ensuring distributed assets by that time.

Given the market’s response to the Secure Act of 2019, which encouraged guaranteed-income options, expect similar offerings from competitors like BlackRock, Capital Group, and T Rowe Price. Investors should monitor how these ETFs perform compared to traditional retirement income products.

Source: Financial Times
Tags: ETFLongevity Income ETFsRetirement incomeStone Ridge
Previous Post

Bitcoin Crashes Below $59K: $230M in Liquidations Rock Crypto Market

Next Post

Goldman Sachs vs. Fed: $6 Billion Stress Test Showdown

Recommended For You

Most “Longevity Drugs” Don’t Work the Way You Think

by Team Lumida
18 hours ago
diagram

Key takeaways Powered by lumidawealth.com Most longevity drugs improve markers, not actual lifespan. Human evidence is weak for many popular compounds. Drug benefits are context-dependent — not universal. Lifestyle...

Read more

Walking After Meals Is a Simple Hack for Blood Sugar Control

by Team Lumida
2 days ago
woman walking on pathway during daytime

Key takeaways Powered by lumidawealth.com Just 10–15 minutes of walking after meals can lower post-meal blood sugar spikes. Light activity helps muscles absorb glucose without needing as much insulin....

Read more

Ozempic’s Patent Expiry Could Make India the Biggest Test Case for Cheap Weight-Loss Drugs

by Team Lumida
2 days ago
Ozempic’s Patent Expiry Could Make India the Biggest Test Case for Cheap Weight-Loss Drugs

Key takeaways Powered by lumidawealth.com India is about to become a major generic GLP-1 market, with multiple drugmakers preparing cheaper semaglutide launches after patent expiry. Prices could fall by...

Read more

Vinegar Before Meals May Help Control Blood Sugar

by Team Lumida
5 days ago
Several small glass bottles with orange liquid

Key takeaways Powered by lumidawealth.com 1–2 tablespoons of vinegar before meals can lower post-meal glucose spikes. Acetic acid slows carbohydrate digestion and glucose absorption. Studies show vinegar can improve...

Read more

Avocados Are the Metabolic Health Hack Most Diets Miss

by Team Lumida
6 days ago
sliced green avocado fruit

Key takeaways Powered by lumidawealth.com Avocados are rich in monounsaturated fats that support heart and metabolic health. High fiber content helps regulate blood sugar and appetite. They provide potassium,...

Read more

Fiber Before Meals Is the Natural GLP-1 Hack

by Team Lumida
7 days ago
Fiber Before Meals Is the Natural GLP-1 Hack

Key takeaways Powered by lumidawealth.com Fiber stimulates GLP-1, the same hormone targeted by popular weight-loss drugs. Eating fiber before meals reduces appetite and slows glucose spikes. It improves gut...

Read more

Walking After Meals Is the Longevity Hack

by Team Lumida
1 week ago
shallow focus photography of person walking on road between grass

Key takeaways Powered by lumidawealth.com A 10–15 minute walk after meals significantly lowers blood sugar spikes. Post-meal walking improves insulin sensitivity and metabolic health. Regular light movement after eating...

Read more

Fiber Is the Longevity Hack Most Diets Still Miss

by Team Lumida
1 week ago
green leaves on blue plastic bowl

Key takeaways Powered by lumidawealth.com Higher fiber intake is associated with lower mortality and chronic disease risk. Fiber improves gut microbiome health, which affects metabolism, immunity, and inflammation. Most...

Read more

Mobile Screens Are the Modern Health Risk Hiding in Plain Sight

by Team Lumida
2 weeks ago
person holding blue and white box

Key takeaways Powered by lumidawealth.com High mobile screen time is linked to poorer sleep quality, largely due to blue light exposure and late-night device use. Digital overuse contributes to...

Read more

Protein Timing Is the Longevity Multiplier

by Team Lumida
2 weeks ago
a container of protein powder next to a spoon

Key takeaways Most adults under-consume protein at breakfast and overconsume it at dinner. Muscle protein synthesis is optimized when ~25–40g of protein is consumed per meal. Even distribution...

Read more
Next Post
Goldman’s Big Bet on Wealth Lending: Doubling Down on the Ultra-Rich

Goldman Sachs vs. Fed: $6 Billion Stress Test Showdown

Fed Minutes Reveal Reluctance to Cut Rates Amid Inflation Worries

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

a close up of a computer screen with a message on it

OpenAI Secures $12 Billion Cloud Deal with CoreWeave Ahead of IPO

March 11, 2025
Powell Signals Patience: Fed to Lower Rates ‘Over Time’

Powell’s Last Stand: Balancing a Tricky Economy and Intense Political Pressure

September 18, 2025
Microsoft’s AI Ambitions: A Costly Path Forward

Microsoft’s Copilot Stumbles as OpenAI Tie-Up Fades, and Users Drift to ChatGPT and Gemini

February 4, 2026

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018